Meaghan Kennedy

Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering of 12,105,263 shares of common stock of Generation Bio Co., which…

Davis Polk advised the underwriter in connection with a $100 million SEC-registered underwritten primary block trade of 1,222,942 common shares of Black Hills Corporation. The common shares…

Davis Polk advised the underwriter in connection with a block trade of 15,430,841 common shares of Genpact Limited by funds affiliated with Bain Capital Investors, LLC and its co-investor…

Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of 7,500,000 equity units,…

Davis Polk advised the underwriters in connection with the $150 million initial public offering of 10,000,000 American Depositary Shares of BioNTech SE. In addition, the underwriters have…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Etsy, Inc. of $650 million aggregate principal amount of its 0.125% convertible…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insulet Corporation of $800 million principal amount of 0.375% convertible senior notes due 2026,…

Davis Polk advised the forward purchasers and forward sellers in connection with an at-the-market forward underwriting program for the offer and sale of shares of common stock of Piedmont…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by YY Inc. (NASDAQ: YY) of $425 million aggregate principal amount of 0.750% convertible…

Davis Polk advised the representatives of the underwriters in connection with the $163.3 million initial public offering of 9,074,776 shares of common stock of Stoke Therapeutics, Inc.,…